Industry News
Analytica close to US, EU filings for PeriCoach
Analytica (ASX:ALT) will soon be ready to file EU CE Mark and US 510(k) submissions for PeriCoach, a device for treating female urinary incontinence that is already approved in Australia. [ + ]
pSivida partner files fourth US NDA for Iluvien
pSivida (ASX:PVA) licensee Alimera Sciences has made its third resubmission of its US New Drug Application for diabetic macular edema treatment Iluvien. [ + ]
GI Dynamics hits Netherlands reimbursement milestone
A Dutch hospital has won approval to be reimbursed for some procedures involving GI Dynamics' (ASX:GID) EndoBarrier so that healthcare authorities can evaluate allowing nationwide reimbursement. [ + ]
Academy Fellowships
Twenty-one new fellows have been elected to the Australian Academy of Science. [ + ]
A vaccine for middle ear infections
A team of international researchers has moved a step closer to developing a vaccine to protect against middle ear infection, which could also be used for those with poor lung function. [ + ]
Extreme weather directs insect and reptile distribution
The distribution of cold-blooded creatures such as insects, spiders and skinks is predicted to shift rapidly due to extreme weather events associated with climate change. [ + ]
Government releases statement on the Pharmaceutical Patents Review
The federal government last week released a statement on the Pharmaceutical Patents Review report, confirming it "has no plans to respond to the report at this stage". [ + ]
Crude oil linked to heart defects in fish
Oil spills, such as the 2010 Deepwater Horizon spill in the Gulf of Mexico, cause heart defects in developing fish embryos. [ + ]
Novogen JV's ovarian cancer drug effective in vivo
CanTx, a JV between Novogen (ASX:NRT) and Yale University, said its lead drug candidate Trx-1 induced an anti-tumoural effect in a mouse model of ovarian cancer. [ + ]
Prima adds three more experts to advisory board
Prima BioMed (ASX:PRR) has chosen three gynaecological oncology experts to join its clinical advisory board as it prepares for a new trial of CVac in epithelial ovarian cancer. [ + ]
GE acquires strategic assets from Thermo Fisher Scientific
GE Healthcare has completed its acquisition of three businesses from Thermo Fisher Scientific: HyClone cell culture media, Dharmacon RNAi gene modulation and Sera-Mag magnetic beads. [ + ]
2014 Fellows of the Australian Academy of Science announced
The Australian Academy of Science has announced the election of 21 leaders in Australian science to its Fellowship. [ + ]
GTG reaches settlement deal with Promega
Genetic Technologies (ASX:GTG) has reached a deal to license its genomic mapping patents to US-based Promega Corporation. [ + ]
Sirtex and Guerbet team for liver cancer studies
Sirtex Medical (ASX:SRX) has signed an agreement to evaluate using its SIR-Spheres microspheres in conjunction with Guerbet's Lipidol to treat a range of liver cancers. [ + ]
Cochlear's first-of-its-kind hybrid device gets regulatory approval in US
After the US FDA approved the first-of-its-kind hearing device, Cochlear has launched a new hybrid hearing solution that helps people's hearing by amplifying low-frequency hearing and restoring access to high-frequency hearing, and will open up new opportunities in the US market. [ + ]
